News


Novo pacemaker pode salvar (ainda mais) vidas

A insuficiência cardíaca afeta 250 mil portugueses. Na Faculdade de Medicina da Universidade do Porto, o cirurgião Adelino Leite-Moreira está a desenvolver uma terapia inovadora para tratá-la. (...)

Faculdade de Medicina do Porto vai recrutar 200 grávidas para estudo

A Faculdade de Medicina da Universidade do Porto (FMUP) anunciou esta terça-feira que pretende recrutar mais de 200 grávidas com o objetivo de acompanhar as alterações cardíacas durante e após a gestação. Os resultados desta investigação poderão abrir caminho a novas formas de tratar a insuficiência cardíaca, uma das principais causas de morte no mundo. (...)

Projeto estuda coração de mulheres grávidas para investigar a insuficiência cardíaca

Inês Falcão Pires, investigadora na Unidade de Investigação Cardiovascular (UnIC) e professora na Faculdade de Medicina da Universidade do Porto (FMUP), está a desenvolver o projeto PERIMYR com o objetivo de melhor compreender os processos de regulação e recuperação cardíaca do coração. (...)

About Us

The Cardiovascular R&D Unit (UnIC) was created in 1994 to fill a gap in the translational research of cardiovascular diseases. At the moment, the Centre integrates basic science (Physiology) and clinical departments (Cardiology, Internal Medicine, Cardio-thoracic and Vascular Surgery, Neurology, Pediatrics and Pediatrics Cardiology), assembling investigators from several Departments of the Faculty of Medicine of Porto, from Centro Hospitalar de São João, EPE (CHSJ) among others, accounting 124 researchers, 38 of which are PhD holders. The combination of different basic science and clinical departments allows the implementation of bench to bedside to bench approaches in the study of cardiovascular (CV) diseases, with a significant number of its investigators combining research with clinical activity.

Currently, we are the major Centre in Portugal devoted to the translational approach of CV diseases that currently represent a major burden in aged western societies. Indeed, in this area, we are in the frontline regarding scientific productivity, training and implementing innovative therapeutic approaches. Thus, considering our know-how of almost 20 years in specialized CV research, we feel that updating and expanding our current equipment and services to the public (clinics, scientists, engineers and sports professionals) would allow us to substantially increase the knowledge on CV disease physiology and therapy.

Contact Us

Please fill the form below to send us a mesage